J&J recalls Aveeno, Neutrogena sunscreens after carcinogen found in sprays

Johnson & Johnson said it is voluntarily recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen products from the market after detecting a cancer-causing chemical in some samples

Johnson & Johnson
Reuters
2 min read Last Updated : Jul 15 2021 | 7:25 AM IST

(Reuters) - Johnson & Johnson said on Wednesday it is voluntarily recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen products from the market after detecting a cancer-causing chemical in some samples.

After internal testing identified low levels of benzene in some samples, J&J said it has decided to recall these products from the market.

Benzene is classified as a human carcinogen, a substance that could potentially cause cancer depending on the level and extent of exposure.

"While benzene is not an  ingredient in  any of our  sunscreen products, it was detected in some samples of the impacted aerosol sunscreen finished products," the company said.

"Daily exposure to benzene in these aerosol sunscreen products at the levels detected in our testing would not be expected to cause adverse health consequences."

However, the company said it is recalling all lots of these specific aerosol sunscreen products out of caution.

The recalled aerosol sunscreens are Neutrogena Beach Defense, Neutrogena Cool Dry Sport, Neutrogena Invisible Daily defense, Neutrogena Ultra Sheer, and Aveeno Protect + Refresh.

J&J said consumers should stop using the affected products and appropriately discard them.

Consumers should contact their physician or healthcare provider if they have any concerns, questions or have experienced any problems related to using these products.

 

(Reporting by Sabahatjahan Contractor in Bengaluru; Editing by Subhranshu Sahu)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Johnson & JohnsonChemicals in sunscreencancer

First Published: Jul 15 2021 | 7:25 AM IST

Next Story